Literature DB >> 25342460

Sinulolides A-H, new cyclopentenone and butenolide derivatives from soft coral Sinularia sp.

Bin Yang1, Xiaoyi Wei2, Jingxia Huang3, Xiuping Lin4, Juan Liu5, Shengrong Liao6, Junfeng Wang7, Xuefeng Zhou8, Lishu Wang9, Yonghong Liu10.   

Abstract

Eight new compounds, sinulolides A-H (1-8), along with two known compounds, α-methoxy-2,3-dimethyl-butenolide (9) and sinularone D (10), were isolated from the soft coral Sinularia sp. The structures of these compounds were elucidated on the basis of extensive spectroscopic analysis. The absolute configurations were determined on the basis of electronic circular dichroism (ECD) data analysis. Compounds 5 and 10 exhibited moderate effects for the inhibition of NF-κB activation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25342460      PMCID: PMC4210901          DOI: 10.3390/md12105316

Source DB:  PubMed          Journal:  Mar Drugs        ISSN: 1660-3397            Impact factor:   5.118


1. Introduction

Genus Sinularia is a soft coral belonging to the phylum, Cnidaria, class Alcyonaria and family Alcyoniidae. It constitutes a dominant portion of the biomass in the tropical reef environment [1]. Many bioactive metabolites, including sesquiterpenes [2,3,4], diterpenes [5,6,7,8,9] and polyhydroxylated steroids [10,11,12], have been studied, and the isolated components display a range of biological activities, such as antimicrobial, anti-inflammatory, glucose transport in rat adipocytes and cytotoxic activities [13,14,15,16,17]. During the course of our investigation on the bioactive chemical constituents from the soft coral, eight new compounds, sinulolides A–H (1–8), along with two known compounds, α-methoxy-2,3-dimethyl-butenolide (9) and sinularone D (10) (Figure 1), were isolated from Sinularia sp., collected off the Dongluo Island, Sanya, in July, 2009, at a depth of 10 m. The bioactivities of these compounds were determined through bioactivity tests using high-throughput screening (HTS). We describe herein the isolation, structure elucidation and bioactivities of these compounds.
Figure 1

Structures of metabolites 1–10.

Structures of metabolites 1–10.

2. Results and Discussion

Compound 1 was isolated as a colorless oil. Its molecular formula was assigned as C20H30O6 based on the HRESIMS at m/z 367.2117 [M + H]+, accounting for six degrees of unsaturation. The 1H NMR spectrum indicated the presence of one methoxyl singlet (δH 3.66, s, H-16), four methyl singlets (δH 2.01, H-1, 1.83, H-19, 1.82, H-20, 1.04, H-18), one methyl doublet (δH 1.15, t, J = 7.0 Hz, H-17) and a low-field exchangeable hydroxyl proton (δH 4.72, s, H-3), in addition to 11 aliphatic protons (Table 1). The 13C-NMR and HMQC spectra of 1 showed the presence of six methyls, five methylenes, one methine and eight quaternary carbons, including two olefinic carbonsC 163.1, 139.5), three oxygen-bearing quaternary carbonsC 89.1, 92.3, 86.7), two ketonesC 207.0, 204.7) and one carbonyl (δC 177.4). The above functionalities account for four of the six degrees of unsaturation in the molecule, revealing a bicyclic structure for 1. The 1H and 13C NMR spectra of 1 were similar to those of α-tocospiro A [18,19], with the difference of the side-chain, which was confirmed by the HMBC experiment. The HMBC interactions from H3-16 to C-15, H-13 to C-12, C-14, C-15 and C-17, H-14 to C-12, C-13, C-15 and C-17 and H3-17 to C-13, C-14 and C-15 led to the connectivity of the subunits to form a linear chain (Figure 2). Subsequently, the linear side chain was determined to be linked to the nucleus at C-10 on the basis of the HMBC interactions from H3-18 to C-9, C-10 and C-11. For the spiro moiety, the relative stereochemistry was shown to be the same as that of α-tocospiro A on the basis of similar specific rotation and the NOESY spectrum. Circular dichroism (CD) data also support the absolute configuration of 1 to be identical to that of α-tocospiro C [20]. The absolute configuration was further determined by electronic circular dichroism (ECD) (Figure 3). The calculated ECD showed diagnostic cotton effects around 226 (positive), 246 (negative) and 287 (positive) nm, consistent with the experimental ECD. Thus, the absolute configuration was established as 3S, 7R and 10S, whereas the configurations at C-14 remained to be determined.
Table 1

1H and 13CNMR spectroscopic data for compounds 1 and 2 (500/125 MHz, in CDCl3, δ in ppm, J in Hz).

Position12
13C1H13C1H
125.02.01 s24.82.01 s
2207.0 207.0
389.14.72 s89.44.68 s
4163.1 163.2
5139.5 139.5
6204.7 205.0
792.3 92.7
836.51.87 m36.81.88 m
1.76 m 1.76 m
933.02.41 m33.32.38 m
1.76 m 1.76 m
1086.7 86.9
1141.01.62 m41.41.62 m
1222.51.41 m22.51.41 m
1.36 m 1.36 m
1334.41.67 m34.21.64 m
1.41 m 1.40 m
1439.52.48 m39.32.44 m
15177.4 177.2
1651.53.66 s51.53.67 s
1717.21.15 d (7.0)17.01.14 d (7.0)
1825.71.04 s25.41.29 s
1912.01.83 s11.81.83 s
208.91.82 s8.71.81 s
Figure 2

Key HMBC correlations of compounds 1 and 3.

Figure 3

Calculated and experimental electronic circular dichroism (ECD) spectra of compound 1.

1H and 13CNMR spectroscopic data for compounds 1 and 2 (500/125 MHz, in CDCl3, δ in ppm, J in Hz). Key HMBC correlations of compounds 1 and 3. Calculated and experimental electronic circular dichroism (ECD) spectra of compound 1. The NMR spectroscopic data of 1 and 2 are very similar, except for the downfield shift of CH3-18 (1.04→1.29) (Table 1), implying 2 to be a C-10 epimer of 1, as is evident from α-tocospiro B [18,19]. However, the optical rotation and the CD spectrum of 2 are the opposite sign to the data of 1. The measured CD curve of 2 was very similar to the calculated ECD for 3R, 7S, 10S-isomer, opposite of the data for 1 (Figure 4), indicating 2 to be in agreement with 3R, 7S and 10S.
Figure 4

Calculated and experimental ECD spectra of compound 2.

Calculated and experimental ECD spectra of compound 2. Compound 3 was isolated as a colorless oil. The ion peak was observed in ESI-MS at m/z 291 [M + Na]+, 559 [2M + Na]+. The 1H NMR spectrum indicated the presence of one methoxyl singlet (δH 3.75, s, H-15), two methyl singlets (δH 2.00, H-13, 1.72, H-14) and one terminal methyl triplet (δH 0.83, t, J = 7.0 Hz, H-12) (Table 2). The 13C NMR and HMQC spectra of 3 showed the presence of four methyls, five methylenes one methine, as well as five quaternary carbons, including two olefinic carbonsC 168.7, 135.5), one oxygen-bearing quaternary carbonC 80.4), one ketoneC 202.8) and one carbonyl (δC 175.2). The 1H and 13C NMR spectra of 3 were almost the same as those of sinularone B [21]. The distinction was attributed to the presence of a methyl ester to replace an ethyl ester of the known analogue, as is evident from the molecular weight of 3, to be 14 amu less than that of the latter, as well as the presence of a methoxyl group in its NMR spectra (Figure 2).
Table 2

1H and 13CNMR spectroscopic data for compounds 3–6 (500/125 MHz, in CDCl3, δ in ppm, J in Hz).

Position3456
13C1H13C1H13C1H13C1H
1175.2 174.3 175.5 174.4
229.83.15 dd (4.5, 15.5)31.72.98 m29.63.05 dd (3.0, 18.0)28.63.05 dd (4.5, 8.0)
2.39 dd (7.0, 11.5) 2.62 d (15.5) 2.69 dd (6.5, 11.5 ) 2.61 dd (4.5, 14.5)
355.02.85 dd (3.5, 8.5)46.62.93 m60.92.98 dd (3.0, 11.5)60.32.94 dd (7.0,12.5)
4202.8 204.1 203.1 204.4
5135.5 139.0 136.9 140.2
6168.7 167.1 165.9 165.7
780.4 92.3 83.7 80.8
837.01.76 td (19.0, 5.5)34.51.97 td (14.0, 4.0)86.93.29 dd (4.5, 8.0)93.03.61 dd (2.5, 8.5)
1.52 td (13.0, 3.5) 1.81 m
925.10.75 m23.30.88 m31.31.64 m30.61.68 m
0.63 m 1.10 m 1.22 m 1.30 m
1031.91.19 m32.51.32 m32.01.24 m32.21.34 m
1122.41.19 m22.41.25 m22.61.39 m22.81.34 m
1.07 m 1.51 m
1213.90.83 t (7.0)13.90.89 t (7.0)13.90.83 t (7.0)14.00.92 t (7.0 )
137.81.72 s8.21.75 s8.01.72 s8.31.75 s
1411.52.00 s12.22.06 s11.81.99 s13.02.06 s
1552.43.75 s 52.13.74 s44.03.38 s
16 54.73.42 s
Compound 4 was isolated as a colorless oil. The ion peak was observed in ESI-MS at m/z 253 [M − H]−. The 1H and 13C NMR spectra of 4 were almost the same as those of 3, except for the absence of a methoxyl group at C-15 (δC 52.4) in 4 (Table 2). Compound 5 was isolated as a colorless oil. The ion peak was observed in ESI-MS at m/z 299 [M + H]+, 321 [M + Na]+. Comparison with 5 showed almost the same NMR spectroscopic data as 3, except for the presence of a methoxyl carbon at δC 54.7 and a oxygenated methine at δC 86.9, while a methylene signal appeared at δC 37.0 in 3 (Table 2). This implied that a methoxyl group is located at C-8 in 5 instead of the methylene group in 3. The assumption was confirmed by the correlations of CH3-15 to C-8 and H-8 to C-9 and C-3 in the HMBC experiment. Compound 6 was isolated as a colorless oil. The ion peak was observed in ESI-MS at m/z 283 [M − H]−. Close comparison of the 13C NMR spectrum of Compound 6 to that of 5 showed a general similarity, except for the absence of a methoxyl carbon at δC 54.7 at the C-16 position in 5 (Table 2). The measured CD curve of 3–6 was very similar to the calculated ECD for 4R, 5R-isomer and opposite of the data for sinularone B [21], indicating 3–6 to be in agreement with 4R and 5R. Compound 7 was isolated as a colorless oil. The ion peak was observed in ESI-MS at m/z: 279 [M + Na]+, 535 [2M + Na]+. The 1H NMR spectrum suggested the presence of two methyl singlets (δH 1.85, s, H-10, 11) and two methoxyl singlets (δH 3.66, s, H-12, 3.08, s, H-13). The 13C NMR spectrum indicated the presence of four methyls, four methylenes and five quaternary carbons, including two carbonyl groups, two olefinic carbons and one oxygen-bearing quaternary carbon. Both the 1H and 13C NMR spectra of 7 showed a close similarity to 2,3-dimethyl butenolide [22,23], except for the absence of eight methylenes in the methoxycarbonyl side chain and the presence of an additional methoxy group. Comparison of the 1H and 13C NMR spectrum of 7 and 8 revealed that there were two fewer methylenes in the side chain in 8. The negative specific rotation and the opposite Cotton effect in comparison with those of sinularone H indicated that C-4 had an R configuration [21,22]. By comparing the 1H, 13C-NMR and MS data with the literature values, the known Compounds 9 and 10 were identified as ã-methoxy-2,3-dimethyl-butenolide [24] and sinularone D [21], respectively. 1H and 13CNMR spectroscopic data for compounds 3–6 (500/125 MHz, in CDCl3, δ in ppm, J in Hz). Using HTS, all compounds were tested toward Forkhead box O 3α (Foxo3α), 3-hydroxy-3-methylglutaryl CoA reductase gene fluorescent protein (HMGCR-GFP), nuclear factor kappa B (NF-κB) luciferase, peroxisome proliferator-activated receptor-g co-activator 1α (PGC-1α), protein-tyrosine phosphatase 1B (PTP1B), mitochondrial membrane permeabilization (MMP) and adenosine monophosphate-activated protein kinase (AMPK) activity. Compounds 3–8 and 10 were evaluated for inhibition of NF-κB activation, and the inhibitory rates are listed in Table 3. At a concentration of 10 μg/mL, sinulolide E and sinularone D exhibited moderate effects with inhibitory rates of 38.12% and 43.00%, respectively. However, all compounds were inactive against other biological targets.
Table 3

Inhibitory rates of NF-κB activation of Compounds 3–8 and 10.

ConcentrationIR (%)
34567810
10 μg/mL27.8528.7538.1228.2427.0825.2843.00
Inhibitory rates of NF-κB activation of Compounds 3–8 and 10.

3. Experimental Section

3.1. General Experimental Procedures

The NMR spectra were recorded on a Bruker AC 500NMR spectrometer (Bruker BioSpin, Fällanden, Switzerland) with tetramethylsilane (TMS) as an internal standard. ESI-MS data were measured on a Bruker amaZon SL spectrometer (Bruker, Fällanden, Switzerland). HR-ESI-MS data were measured on a Bruker micro TOF-QII mass spectrometer (Bruker, Fällanden, Switzerland). CD spectra were measured with a Chirascan circular dichroism spectrometer (Applied Photophysics Ltd., Leatherhead, UK). Optical rotation values were measured with an Anton Paar MCP500 polarimeter (Anton Paar, Graz, Austria). YMC gel (ODS-A, 12 nm, S-50 µm, YMC, Kyoto, Japan) was used for column chromatography. The SiO2 GF254 used for TLC was supplied by the Qingdao Marine Chemical Factory, Qingdao, China. Sephadex LH-20 gel (GE Healthcare, Uppsala, Sweden) was used. HPLC was carried out on a Hitachi L-2400 (Hitachi, Tokyo, Japan) with a YMC ODS column. Spots were detected on TLC under UV light or by heating after spraying with 5% H2SO4 in EtOH (v/v).

3.2. Animal Material

The soft coral Sinularia sp. was collected from Dongluo Island, Hainan province of China, in July, 2009 (7–10-m depth) and identified by Professor Hui Huang, South China Sea Institute of Oceanology, Chinese Academy of Sciences. A voucher specimen (No. 0907010) was deposited in the CAS Key Laboratory of Tropical Marine Bio-resources and Ecology, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou, China.

3.3. Extraction and Isolation

The fresh soft coral (wet, 6 kg) was extracted three times with 95% EtOH (20 L). The extract was concentrated under reduced pressure and partitioned between H2O (4 L) and CHCl3 (4 L); the CHCl3 layer (120 g) was further partitioned between 85% EtOH (4 L) and petroleum ether (PE; 4 L) to yield 85% EtOH (34 g) and PE (75.6 g) fractions. The 85% EtOH fraction was separated by silica gel column using CHCl3/MeOH to yield 11 portions (Fr. s1–s11). Fr. s3 was purified by silica gel column to yield 12 portions, and Portion 10 was further purified with semi-preparative HPLC, eluting with MeOH/H2O = 65:35 at a flow rate of 2 mL/min, to afford 1 (4.5 mg) and 2 (2.4 mg). Fr. s5 was purified by Sephadex LH-20 using CHCl3/MeOH = 1:1 to yield 3 portions, and Portion 3 was further purified with semi-preparative HPLC, eluting with MeOH/H2O = 57:43 at a flow rate of 2 mL/min, to afford 7 (3.0 mg), 8 (4.1 mg) and 9 (10.0 mg). Fr. s6 was further purified with semi-preparative HPLC, eluting with MeOH/H2O = 60:40 at a flow rate of 2 mL/min, to afford 3 (2.4 mg), 4 (2.8 mg) and 10 (6.7 mg). Fr. s7 was purified by Sephadex LH-20 to yield three portions, and Portion 3 was further purified with semi-preparative HPLC, eluting with MeOH/H2O = 60:40 at a flow rate of 2 mL/min, to afford 5 (3.5 mg) and 6 (4.2 mg). Sinulolide A (1): colorless oil; = −172.5 (c = 0.35, MeOH); CD (MeOH; c 0.2): Δε287 −9.72, Δε246 +12.72, Δε226 −0.76; 1H and 13C NMR data: see Table 1; HRESIMS m/z 367.2117 [M + H]+ (calcd. for C20H31O6, 367.2115), 389.1942 [M + Na]+ (calcd. for C20H30O6Na, 389.1935). Sinulolide B (2): colorless oil; = +103.2 (c = 0.07, MeOH); CD (MeOH; c 0.2): Δε287 +3.94, Δε246 −4.66, Δε226 +0.51; 1H and 13C NMR data: see Table 1; ESI-MS m/z 367 [M + H]+, 389 [M + Na]+, 755 [2M + Na]+. Sinulolide C (3): colorless oil; = −3.2 (c = 0.01, MeOH); CD (MeOH; c 0.2): Δε210 −0.23; 1H and 13C NMR data: see Table 2; ESI-MS m/z 291 [M + Na]+, 559 [2M + Na]+. Sinulolide D (4): colorless oil; = −2.5 (c = 0.01, MeOH); CD (MeOH; c 0.2): Δε207 –0.48, Δε238 −0.46; 1H and 13C NMR data: see Table 2; ESI-MS m/z 253 [M – H]−. Sinulolide E (5): colorless oil; = −3.8 (c = 0.01, MeOH); CD (MeOH; c 0.2): Δε218 –0.52; 1H and 13C NMR data: see Table 2; ESI-MS m/z 299 [M + H]+, 321 [M + Na]+. Sinulolide F (6): colorless oil; = −6.6 (c = 0.01, MeOH); CD (MeOH; c 0.2): Δε206 −0.48; 1H and 13C NMR data: see Table 2; ESI-MS m/z 283 [M − H] −. Sinulolide G (7): colorless oil; = −4.4 (c = 0.05, MeOH); CD (MeOH; c 0.2): Δε229 −0.4; 1H NMR (500 MHz, CDCl3) δ: 3.66 (3H, s), 3.08 (3H, s), 2.29 (2H, m), 1.99 (1H, m), 1.85 (6H, s), 1.70 (1H, m), 1.61 (2H, m), 1.23 (2H, m); 13C NMR (125 MHz, CDCl3) δ: 173.4 (C, C-9), 171.9 (C, C-1), 155.6 (C, C-3), 127.4 (C, C-2), 109.5 (C, C-4), 51.6 (CH3, C-10), 50.1 (CH3, C-11), 35.3 (CH2, C-5), 33.8 (CH2, C-8), 24.8 (CH2, C-6), 22.3 (CH2, C-7), 10.7 (CH3, C-13), 8.5 (CH3, C-12); ESI-MS m/z: 279 [M + Na]+, 535 [2M + Na]+. Sinulolide H (8): colorless oil; = −3.2 (c = 0.03, MeOH); CD (MeOH; c 0.2): Δε229 −0.4; 1H NMR (500 MHz, CDCl3) δ: 3.66 (3H, s), 3.07 (3H, s), 2.52 (1H, m), 2.39 (1H, m), 2.30 (1H, m), 1.96 (1H, m), 1.88 (3H, s), 1.85 (3H, s); 13C NMR (125 MHz, CDCl3) δ: 173.2 (C, C-7), 171.2 (C, C-1), 155.7 (C, C-3), 127.7 (C, C-2), 108.9 (C, C-4), 51.8 (CH3, C-8), 50.2 (CH3, C-9), 31.2 (CH2, C-5), 27.8 (CH2, C-6), 10.7 (CH3, C-11), 8.5 (CH3, C-10); ESI-MS at m/z: 251 [M + Na]+, 479 [2M + Na]+.

3.4. Assays for Bioactivities

Bioactivity assays were performed by the National Center for Drug Screening, the State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, using HTS [25]. Previously reported procedures were followed for assaying the bioactivity against Foxo3α [26], HMGCR-GFP [27], NF-κB luciferase [28], PGC-1α [29], PTP1B [30], MMP [31] and AMPK [32].

3.5. Computational Calculation

The computational ECD, specific rotation and 13C NMR calculations were performed by the B3LYP functional and a generic basis set, employing the 6-311+G (d,p) basis set [21,33]. This generic basis set has been shown to be effective, both efficient and reliable, in predicting structural and reactivity properties for homogeneous systems. Molecular Merck force field (MMFF) and density functional theory/time dependent density functional theory (DFT/TDDFT) calculations were performed with Spartan’14 software package (Wavefunction Inc., Irvine, CA, USA) and the Gaussian 09 program package, respectively, using default grids and convergence criteria.

4. Conclusions

Our study revealed the chemical constituents of soft coral Sinularia sp., which is rich in the South China Sea. Ten compounds were isolated and purified, including seven cyclopentenone derivatives and three butenolide derivatives. Using HTS, their bioactivities toward several targets, such as Foxo3α, HMGCR-GFP, NF-κB-luciferase, PGC-1a, PTP1B, MMP and AMPK, were evaluated. Compounds 5 and 10 exhibited moderate effects for the inhibition of NF-κB activation.
  20 in total

1.  Polyhydroxylated steroids from the soft coral Sinularia dissecta.

Authors:  Pengfei Jin; Zhiwei Deng; Yuehu Pei; Hongzheng Fu; Jun Li; Leen Van Ofwegen; Peter Proksch; Wenhan Lin
Journal:  Steroids       Date:  2005-07       Impact factor: 2.668

2.  A new 2,3-dimethyl butenolide from the brittle star Ophiomastix mixta.

Authors:  Jinsoo Lee; Weihong Wang; Jongki Hong; Chong-Ok Lee; Sook Shin; Kwang Sik Im; Jee Hyung Jung
Journal:  Chem Pharm Bull (Tokyo)       Date:  2007-03       Impact factor: 1.645

3.  Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation.

Authors:  Zoltan Arany; Bridget K Wagner; Yanhong Ma; Jessica Chinsomboon; Dina Laznik; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

Review 4.  Metabolites from Sinularia species.

Authors:  V Lakshmi; R Kumar
Journal:  Nat Prod Res       Date:  2009       Impact factor: 2.861

5.  Phenotype-based high-content chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesis.

Authors:  Martin Michael Peter Schulz; Felix Reisen; Silvana Zgraggen; Stephanie Fischer; Don Yuen; Gyeong Jin Kang; Lu Chen; Gisbert Schneider; Michael Detmar
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

6.  Cytotoxic cembranoid diterpenes from a soft coral Sinularia gibberosa.

Authors:  Guoqiang Li; Yanling Zhang; Zhiwei Deng; Leen van Ofwegen; Peter Proksch; Wenhan Lin
Journal:  J Nat Prod       Date:  2005-05       Impact factor: 4.050

7.  Polyoxygenated sterols from the Formosan soft coral Sinularia gibberosa.

Authors:  Atallah F Ahmed; Ya-Ting Hsieh; Zhi-Hong Wen; Yang-Chang Wu; Jyh-Horng Sheu
Journal:  J Nat Prod       Date:  2006-09       Impact factor: 4.050

8.  Oxygenated cembranoids from a Formosan soft coral Sinularia gibberosa.

Authors:  Atallah F Ahmed; Zhi-Hong Wen; Jui-Hsin Su; Ya-Ting Hsieh; Yang-Chang Wu; Wan-Ping Hu; Jyh-Horng Sheu
Journal:  J Nat Prod       Date:  2008-01-17       Impact factor: 4.050

9.  Potent inhibitors of histamine release: polyhydroxylated sterols from the Okinawan soft coral Sinularia abrupta.

Authors:  N Shoji; A Umeyama; M Takei; S Arihara
Journal:  J Pharm Sci       Date:  1994-05       Impact factor: 3.534

10.  New sinularianin sesquiterpenes from soft coral Sinularia sp.

Authors:  Bin Yang; Shengrong Liao; Xiuping Lin; Junfeng Wang; Juan Liu; Xuefeng Zhou; Xianwen Yang; Yonghong Liu
Journal:  Mar Drugs       Date:  2013-12-02       Impact factor: 5.118

View more
  3 in total

1.  Cembrene Diterpenoids with Ether Linkages from Sarcophyton ehrenbergi: An Anti-Proliferation and Molecular-Docking Assessment.

Authors:  Mohamed-Elamir F Hegazy; Abdelsamed I Elshamy; Tarik A Mohamed; Ahmed R Hamed; Mahmoud A A Ibrahim; Shinji Ohta; Paul W Paré
Journal:  Mar Drugs       Date:  2017-06-21       Impact factor: 5.118

Review 2.  Marine Pharmacology in 2014-2015: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, Antiviral, and Anthelmintic Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Aimee J Guerrero; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Fumiaki Nakamura; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2019-12-19       Impact factor: 5.118

Review 3.  Chemical Diversity and Biological Activity of Secondary Metabolites from Soft Coral Genus Sinularia since 2013.

Authors:  Xia Yan; Jing Liu; Xue Leng; Han Ouyang
Journal:  Mar Drugs       Date:  2021-06-11       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.